Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2000
11/23/2000WO2000016098A9 Composite devices incorporating biological material and methods
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO2000007025A3 Methods for predicting drug response, in particular igf-i
11/23/2000WO2000004863A3 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/23/2000DE19939985C1 Determination of penetration of aqueous acrylate dispersions in wood by coating test plate with dispersion containing water blue pigment, drying and measuring penetration by optical methods
11/23/2000DE19926879A1 Detecting, isolating or quantifying basophils, mast cells and their precursors for diagnosing e.g. leukemia, comprises using antibodies
11/23/2000DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers
11/23/2000DE19919982A1 Verfahren zur Ermittlung osteoporotischer Prozesse Procedure for the determination of osteoporotic processes
11/23/2000DE19919634A1 Test zur Bestimmung der Integrität komplexer Phospholipid/Lipid-Strukturen mit Hilfe synthetischer NBD-markierter Acylglyceride und dessen Anwendung zur Bestimmung der Aktivität von Lipasen Test to determine the integrity of complex phospholipid / lipid structures using synthetic NBD-labeled acylglycerides and its application to determination of the activity of lipases
11/23/2000DE19916797A1 Halbleiter-Gassensor mit Gehäuse und Verfahren zur Messung von Gaskonzentrationen Semiconductor gas sensor with a housing and method for measuring gas concentrations
11/23/2000DE19916638A1 Preparing a device with a functional hydrogel surface for detecting analyte molecules, comprises binding organic molecules with a terminal rest and the terminal rest with a receptor group
11/23/2000DE19911292A1 Electronic measuring device for concentrations of cooling lubricant uses a fed-back clock generator to oscillate and supply alternating square-wave voltage for a bridge rectifier and an electrode current held in an emulsion.
11/23/2000DE10024247A1 Sample holder for biological analyses comprises different specific binding substances arranged on different layers of a substrate
11/23/2000DE10017100A1 Fuel characteristic detector has prohibition unit that prevents sampling of input-output data when exhaust air=fuel ratio in specific area fluctuates due to factors other than fuel characteristic
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2374013A1 Protein a based binding domains with desirable activities
11/23/2000CA2373938A1 Compositions and methods for treating cell proliferation disorders
11/23/2000CA2373935A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000CA2373681A1 Pharmaceutical compositions for treating angina and/or anginal equivalents, and kit relating thereto
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373246A1 System for electrochemical quantitative analysis of analytes within a solid phase
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373229A1 Method for optimizing multivariate calibrations
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372980A1 Assays for agonists, agonists and inverse agonists of melanin concentrating hormone (mch) binding to the somatostatin-like receptor (slc-1)
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372851A1 Device and method for monitoring and controlling biologically active fluids
11/23/2000CA2372794A1 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
11/23/2000CA2372783A1 Identifying material from a breast duct
11/23/2000CA2372761A1 Methods for predicting and/or diagnosing the risk of gastric cancer
11/23/2000CA2372667A1 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
11/23/2000CA2372582A1 Novel fab fragment libraries and methods for their use
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372534A1 Differentiated human embryoid cells and a method for producing them
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2372036A1 Compositions of solvents and high concentrations of nucleic acid analogs
11/23/2000CA2371245A1 Crystal structure of ribosomal protein l11/gtpase activating region rrna and uses thereof
11/23/2000CA2371212A1 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2369376A1 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for prevention of cancer in at-risk subjects
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2368833A1 Molecules expressed in hippocampus
11/23/2000CA2368624A1 Novel .beta.-secretase and modulation of .beta.-secretase activity
11/22/2000EP1054260A2 Chemical reagent solid phases, and their applications
11/22/2000EP1054259A1 Method for the identification of a target compound
11/22/2000EP1054258A1 Homogeneous enzyme immunoassay process using second antibody
11/22/2000EP1054257A2 Emulsion for robust sensing of gases
11/22/2000EP1054252A2 Optical measuring device for the determination of transmitted and scattered radiation
11/22/2000EP1054251A1 Method and device for oil deterioration diagnosis
11/22/2000EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents
11/22/2000EP1054018A1 Fab fragment libraries and methods for their use
11/22/2000EP1053759A2 Means and method for determining the level of removed ureminatoxins during a dialysis treatment
11/22/2000EP1053751A1 Compositions and methods for treating cell proliferation disorders
11/22/2000EP1053477A1 Method and apparatus for aspirating and dispensing sample fluids
11/22/2000EP1053476A1 Immunoassay and test kit for assaying fucosylised protein in a biological sample
11/22/2000EP1053475A1 Methods and devices for detecting non-complexed prostate specific antigen
11/22/2000EP1053474A1 Method for the determination of prosthetic infections
11/22/2000EP1053473A1 Method and apparatus for detecting conception in animals
11/22/2000EP1053472A1 Energy transfer dyes
11/22/2000EP1053470A1 Subsampling fiber testing system
11/22/2000EP1053469A1 Gin process control
11/22/2000EP1053468A1 Fiber strength testing system
11/22/2000EP1053467A1 Fiber micronaire testing system
11/22/2000EP1053466A1 High volume fiber testing system
11/22/2000EP1053465A1 Speciated isotope dilution mass spectrometry of reactive species and related methods
11/22/2000EP1053463A1 Grain quality monitor
11/22/2000EP1053462A1 A method for detecting venting of a combustion appliance within an improper space
11/22/2000EP1053377A1 Vehicle door latch mechanism
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053349A1 Methods for identifying therapeutic targets
11/22/2000EP1053348A2 Determination of a genotype of an amplification product at multiple allelic sites
11/22/2000EP1053343A2 Targeting of genetic vaccine vectors
11/22/2000EP1053332A1 Protein
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053322A1 Wnt-10a
11/22/2000EP1053317A1 Use of ribozymes for functionating genes
11/22/2000EP1053312A2 Optimization of immunomodulatory properties of genetic vaccines
11/22/2000EP1053309A1 Compositions and methods for wound healing
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053305A1 SUBSTRATE ANALOGS FOR MurG, METHODS OF MAKING SAME AND ASSAYS USING SAME
11/22/2000EP1053298A1 Integrated microfluidic devices
11/22/2000EP1053253A1 Novel gaba b? receptor dna sequences
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053248A1 Peptide structures and their use in diagnosis of herpes simplex virus type 2
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053055A1 Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis
11/22/2000EP1053007A2 Methods and compositions for modulating leptin activity
11/22/2000EP1052990A2 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
11/22/2000EP1052984A1 Antibacterial agents
1 ... 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 ... 3937